Search Results - "Hunt, Heike"

Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration by Elfimova, Natalia, Sievers, Elisabeth, Eischeid, Hannah, Kwiecinski, Monika, Noetel, Andrea, Hunt, Heike, Becker, Diana, Frommolt, Peter, Quasdorff, Maria, Steffen, Hans Michael, Nürnberg, Peter, Büttner, Reinhard, Teufel, Andreas, Dienes, Hans-Peter, Drebber, Uta, Odenthal, Margarete

“…Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths, worldwide. MicroRNAs, inhibiting gene expression by targeting various…”
Get full text

Practical issues for frozen section diagnosis in gastrointestinal and liver diseases by Miedema, Jayson R, Hunt, Heike V

“…Surgeons frequently utilize frozen sections as a tool to gain information intraoperatively. The use of frozen sections has certain benefits as well as…”
Get full text

Gastric inflammatory fibroid polyp by Woodward, Kimberly, Gangarosa, Lisa M, Hunt, Heike V

Get full text

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas by Wang, P, Dong, Q, Zhang, C, Kuan, P-F, Liu, Y, Jeck, W R, Andersen, J B, Jiang, W, Savich, G L, Tan, T-X, Auman, J T, Hoskins, J M, Misher, A D, Moser, C D, Yourstone, S M, Kim, J W, Cibulskis, K, Getz, G, Hunt, H V, Thorgeirsson, S S, Roberts, L R, Ye, D, Guan, K-L, Xiong, Y, Qin, L-X, Chiang, D Y

“…Mutations in the genes encoding isocitrate dehydrogenase, IDH1 and IDH2 , have been reported in gliomas, myeloid leukemias, chondrosarcomas and thyroid cancer…”
Get full text

Telmisartan Plus Propranolol Improves Liver Fibrosis and Bile Duct Proliferation in the PSC-Like Abcb4.sup.-/- Mouse Model by Mende, Susanne, Schulte, Sigrid, Strack, Ingo, Hunt, Heike, Odenthal, Margarete, Pryymachuck, Galyna, Quasdorff, Maria

“…Background Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease leading to cirrhosis and cholangiocellular carcinoma. Inhibitors of the…”
Get full text

Telmisartan Plus Propranolol Improves Liver Fibrosis and Bile Duct Proliferation in the PSC-Like Abcb4−/− Mouse Model by Mende, Susanne, Schulte, Sigrid, Strack, Ingo, Hunt, Heike, Odenthal, Margarete, Pryymachuck, Galyna, Quasdorff, Maria, Demir, Münevver, Nierhoff, Dirk, Dienes, Hans-Peter, Goeser, Tobias, Steffen, Hans-Michael, Töx, Ulrich

“…Background Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease leading to cirrhosis and cholangiocellular carcinoma. Inhibitors of the…”
Get full text

Telmisartan Plus Propranolol Improves Liver Fibrosis and Bile Duct Proliferation in the PSC-Like Abcb4 super(-/-) Mouse Model by Mende, Susanne, Schulte, Sigrid, Strack, Ingo, Hunt, Heike, Odenthal, Margarete, Pryymachuck, Galyna, Quasdorff, Maria, Demir, Muenevver, Nierhoff, Dirk, Dienes, Hans-Peter, Goeser, Tobias, Steffen, Hans-Michael, Tox, Ulrich

“…Background: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease leading to cirrhosis and cholangiocellular carcinoma. Inhibitors of the…”
Get full text

Telmisartan Plus Propranolol Improves Liver Fibrosis and Bile Duct Proliferation in the PSC-Like Abcb4^sup -/-^ Mouse Model by Mende, Susanne, Schulte, Sigrid, Strack, Ingo, Hunt, Heike, Odenthal, Margarete, Pryymachuck, Galyna, Quasdorff, Maria, Demir, Münevver, Nierhoff, Dirk, Dienes, Hans-peter, Goeser, Tobias, Steffen, Hans-michael, Töx, Ulrich

“…Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease leading to cirrhosis and cholangiocellular carcinoma. Inhibitors of the…”
Get full text

Abstract 1058: Mutations in isocitrate dehydrogenase 1 and 2 are associated with DNA hypermethylation in intrahepatic cholangiocarcinomas by Wang, Pu, Dong, Qiong-Zhu, Zhang, Chong, Kuan, Pei-Fen, Liu, Yufeng, Jeck, William R., Andersen, Jesper B., Auman, James Todd, Hoskins, Janelle M., Kim, Jin Woo, Cibulskis, Kristian, Getz, Gad, Hunt, Heike V., Thorgeirsson, Snorri S., Roberts, Lewis R., Ye, Dan, Guan, Kun-Liang, Xiong, Yue, Qin, Lun-Xiu, Chiang, Derek Y.

“…Cholangiocarcinomas are rare but aggressive cancers, with an increasing incidence and a dismal 5-year survival rate of less than 5%. Mutations in the genes…”
Get full text